Evidence map›Paper›PMID 39307027›Full record

ArticleInternational journal of surgery case reports2024

Primary pulmonary colloid adenocarcinoma: A case report of a rare subtype.

Ryusei Yamada, Nobuyuki Oguri, Fumiya Kawano, Mayu Inomata, Yuichiro Sato, Ryo Maeda

Abstract readCase Reports
In one paragraph

Article in International journal of surgery case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ryusei YamadaDepartment of Thoracic and Breast Surgery, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Nobuyuki OguriDepartment of Diagnostic Pathology, Faculty of Medicine, University of Miyazaki Hospital, Miyazaki, Japan.
Fumiya KawanoDepartment of Thoracic and Breast Surgery, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Mayu InomataDepartment of Thoracic and Breast Surgery, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Yuichiro SatoDepartment of Diagnostic Pathology, Faculty of Medicine, University of Miyazaki Hospital, Miyazaki, Japan.
Ryo MaedaDepartment of Thoracic and Breast Surgery, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan. Electronic address: ryo_maeda@med.miyazaki-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and importancePulmonary colloid adenocarcinoma is an extremely rare subtype of lung adenocarcinoma. Owing to its rarity, the detailed clinical features of colloid adenocarcinoma remain largely unknown. This report describes a case of early-stage colloid adenocarcinoma that recurred soon after resection, including its radiological findings. CASE PRESENTATION: During a routine checkup, a chest roentgenogram revealed an abnormal shadow in the right upper lung field of an asymptomatic 68-year-old man. Computed tomography (CT) showed a well-defined, low-attenuation nodule in the right upper lobe. Right upper lobectomy with mediastinal lymph node dissection was performed. The postoperative histopathological diagnosis indicated pulmonary colloid adenocarcinoma. The pathological stage was classified as T1bN0M0 (stage IA2). Follow-up CT 1 year after the resection revealed an enlarged supraclavicular lymph node and pulmonary nodule in the right lower lobe. Both lesions appeared as well-defined solitary hypoattenuated tumors with minimal enhancement on CT images. Excisional biopsies of both tumors were performed to obtain a definitive diagnosis. Both tumors consisted of abundant mucin in which some tumor cells were floating and were diagnosed as colloid adenocarcinoma recurrences. CLINICAL DISCUSSION: Although colloid adenocarcinoma is generally considered to have indolent clinical behavior, it can recur even in early-stage cases.

conclusionColloid adenocarcinoma is a distinct variant of lung adenocarcinoma, characterized by well-circumscribed mucinous lesions with alveolar wall destruction caused by mucin pools and scant tumor cells. The treatment strategy for colloid adenocarcinoma should follow the guidelines for primary lung cancer.

Indexed as

Case reportColloid adenocarcinomaLung cancerMetastasisRecurrence

Identifiers

PMID39307027
PMCPMC11439834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.